PNC Financial Services Group
KYMR icon

PNC Financial Services Group’s Kymera Therapeutics KYMR Stock Holding History

PNC Financial Services Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Buy
1,547
+262
+20% +$22.5K ﹤0.01% 2548
2026
Q1 		$107K Buy
1,285
+463
+56% +$36.7K ﹤0.01% 2769
2025
Q4 		$64K Buy
822
+34
+4% +$2.3K ﹤0.01% 3067
2025
Q3 		$44.6K Sell
788
-134
-15% -$6.04K ﹤0.01% 3270
2025
Q2 		$40.2K Buy
922
+770
+507% +$26.5K ﹤0.01% 3233
2025
Q1 		$4.16K Buy
152
+39
+35% +$1.42K ﹤0.01% 4130
2024
Q4 		$4.55K Buy
113
+100
+769% +$4.52K ﹤0.01% 4066
2024
Q3 		$615 Hold
13
– – ﹤0.01% 4535
2024
Q2 		$388 Sell
13
-29
-69% -$1K ﹤0.01% 4564
2024
Q1 		$1.69K Buy
42
+4
+11% +$143 ﹤0.01% 4246
2023
Q4 		$967 Buy
+38
New +$680 ﹤0.01% 4324
2021
Q4 		– Sell
-17
Closed -$1K – 4537
2021
Q3 		$1K Buy
+17
New +$986 ﹤0.01% 4205

Other funds holding KYMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

PNC Financial Services Group's KYMR Position: Q2 2026 in Review

PNC Financial Services Group increased its Kymera Therapeutics (KYMR) stake by 20% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,547 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

PNC Financial Services Group first reported a position in KYMR in Q3 2021 and has held it in 12 quarters since. 117 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • PNC Financial Services Group held 1,547 shares of Kymera Therapeutics worth $177K as of Q2 2026.
  • PNC Financial Services Group bought 262 Kymera Therapeutics shares in Q2 2026, an estimated $22.5K.
  • Kymera Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2548 holding.
  • PNC Financial Services Group first reported a position in Kymera Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • 117 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.